Protection Analysis

Panacea community - Protection sales by quarter

Product Q4 17 Q1 18 Q2 18 Q3 18 TOTAL
Crit. Illness £1,325,882 £1,128,900 £1,245,203 £1,220,155 £4,920,140
Decreasing Term with CI £5,373,872 £4,708,432 £4,826,763 £4,750,064 £19,659,130
Income Prot. £3,267,164 £3,044,793 £3,139,543 £3,358,032 £12,809,533
Mortgage Term £10,298,306 £8,506,018 £8,808,168 £9,173,554 £36,786,046
Relevant Life £1,372,284 £1,912,618 £1,907,723 £1,753,562 £6,946,186
Term £19,326,285 £19,262,735 £18,143,688 £16,689,936 £73,422,644
Term with Critical Illness £7,164,131 £6,696,214 £6,649,796 £6,122,466 £26,632,606
Whole of Life £5,142,043 £5,413,641 £4,646,093 £4,866,506 £20,068,283
Grand total £53,269,967 £50,673,351 £49,366,975 £47,934,276 £201,244,568

  

Q3 2018 total Protection sales

Product Non-User Sales (£) Panacea Community Market Sales (£) Grand total Community Market Share
Crit. Illness £3,527,039 £1,220,155 £4,747,194 26%
Decreasing Term with CI £10,950,577 £4,750,064 £15,700,642 30%
Income Prot. £8,113,235 £3,358,032 £11,471,267 29%
Mortgage Term £16,953,746 £9,173,554 £26,127,301 35%
Relevant Life £2,646,672 £1,753,562 £4,400,234 40%
Term £34,903,240 £16,689,936 £51,593,176 32%
Term with Critical Illness £12,700,461 £6,122,466 £18,822,928 33%
Whole of Life £7,003,352 £4,866,506 £11,869,858 41%
Grand total £96,798,323 £47,934,276 £144,732,599 33%

  

Please contact sarahpaul@panaceaadviser.com if you are interested in speaking to us further.

Email this article Print Share on Twitter Share on LinkedIn Share on Facebook Share on Google+